Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.
Autorzy:
de Boer JW; Department of Hematology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. Keijzer K; Department of Hematology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. Pennings ERA; Department of Hematology, Amsterdam UMC Location University of Amsterdam, 1007 MB Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), 1105 AZ Amsterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, 3062 PA Rotterdam, The Netherlands. van Doesum JA; Department of Hematology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. Spanjaart AM; Department of Hematology, Amsterdam UMC Location University of Amsterdam, 1007 MB Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), 1105 AZ Amsterdam, The Netherlands. Jak M; Department of Hematology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands. Mutsaers PGNJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands. van Dorp S; Department of Hematology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands. Vermaat JSP; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands. van Dijk LV; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. Kersten MJ; Department of Hematology, Amsterdam UMC Location University of Amsterdam, 1007 MB Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), 1105 AZ Amsterdam, The Netherlands. Niezink AGH; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. vanMeertenT; Department of Hematology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.
Autorzy:
Spanjaart AM; Department of Hematology, Amsterdam UMC Location University of Amsterdam, 1007 MB Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), 1105 AZ Amsterdam, The Netherlands. Pennings ERA; Department of Hematology, Amsterdam UMC Location University of Amsterdam, 1007 MB Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), 1105 AZ Amsterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, 3062 PA Rotterdam, The Netherlands. Mutsaers PGNJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands. van Dorp S; Department of Hematology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands. Jak M; Department of Hematology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands. van Doesum JA; Department of Hematology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. de Boer JW; Department of Hematology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. Niezink AGH; Department of Radiation Oncology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. Kos M; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Department of Medical Oncology, Amsterdam UMC Location University of Amsterdam, 1081 HV Amsterdam, The Netherlands. Vermaat JSP; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. Sijs-Szabo A; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands. Nijhof IS; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC Location Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.; Department of Internal Medicine-Hematology, St Antonius Hospital, 3435 CM Nieuwegein, The Netherlands. Kuipers MT; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC Location Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands. Chamuleau MED; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC Location Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands. Lugtenburg PJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands. Doorduijn JK; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands. Serroukh YIM; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands. Minnema MC; Department of Hematology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands. vanMeertenT; Department of Hematology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. Kersten MJ; Department of Hematology, Amsterdam UMC Location University of Amsterdam, 1007 MB Amsterdam, The Netherlands.; Cancer Center Amsterdam, 1105 AZ Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), 1105 AZ Amsterdam, The Netherlands.
Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma.
Autorzy:
de Jong MRW; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands. Langendonk M; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands. Reitsma B; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands. Nijland M; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands. van den Berg A; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, the Netherlands. Ammatuna E; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands. Visser L; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, the Netherlands. vanMeertenT; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage.
Autorzy:
de Jong MRW; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, the Netherlands.; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, the Netherlands. Langendonk M; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, the Netherlands.; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, the Netherlands. Reitsma B; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, the Netherlands. Herbers P; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, the Netherlands. Nijland M; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, the Netherlands. Huls G; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, the Netherlands. van den Berg A; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, the Netherlands. Ammatuna E; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, the Netherlands. Visser L; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, the Netherlands. vanMeertenT; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, the Netherlands.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2019 Nov 07; Vol. 11 (11). Date of Electronic Publication: 2019 Nov 07.
Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma.
Autorzy:
Nijland M; Department of Hematology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. . Seitz A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. . Terpstra M; Department of Genetics, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. . van Imhoff GW; Department of Hematology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. g.w.van.. Kluin PM; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. . vanMeertenT; Department of Hematology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. t.van.meerten@umcg.nl. Atayar Ç; Department of Pathology, Treant Caregroup, Bethesda Hospital, 7909 AA Hoogenveen, The Netherlands. . van Kempen LC; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. l.van.. Diepstra A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. . Kok K; Department of Genetics, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. . van den Berg A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. a.van..
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2018 Nov 20; Vol. 10 (11). Date of Electronic Publication: 2018 Nov 20.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
